3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Sarcoma
2
Genitourinary
2
Dermatologic
2
CNS
2
Thoracic
1
NET
1
Myeloid
1
Gynecologic
1
Endocrine
1
Breast
1
Conditions
Neuroendocrine Tumors
73
Carcinoma, Neuroendocrine
27
Pheochromocytoma
24
Thyroid Cancer, Papillary
23
Thyroid Neoplasms
21
Pituitary Neoplasms
21
Adrenocortical Carcinoma
19
Paraganglioma
16
Multiple Endocrine Neoplasia Type 1
14
Neuroblastoma
12
Sarcoma
11
Adenoma, Islet Cell
11
Small Cell Lung Carcinoma
10
Neoplasms
10
Melanoma
10
Lung Neoplasms
9
Carcinoid Tumor
9
Adrenal Gland Neoplasms
9
Adenocarcinoma, Follicular
9
Pancreatic Neoplasms
8
Gastro-enteropancreatic neuroendocrine tumor
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Medullary
8
Thyroid Carcinoma, Anaplastic
7
Neoplasm Metastasis
7
Mesothelioma
7
Cushing Syndrome
7
Cholangiocarcinoma
7
Central Nervous System Neoplasms
7
Breast Neoplasms
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Glandular and Epithelial
×
Endocrine
×
90 days
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled